ZIOPHARM Oncology is a biotechnology company developing cancer therapies founded in 2005.
Ziopharm is developing immunotherapies using Controlled IL-12, which weaponizes the existing immune systemimmune system and Sleeping Beauty-modified T cells, which introduces new immune system elements to fight cancer.